Tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistance. [electronic resource]
Producer: 20080319Description: 355-62 p. digitalISSN:- 1879-1484
- Adult
- Aged
- Alkanesulfonates -- administration & dosage
- Apolipoprotein A-I -- blood
- Apolipoprotein C-III -- blood
- Apolipoproteins -- blood
- Apolipoproteins B -- blood
- Cholesterol, LDL -- blood
- Dose-Response Relationship, Drug
- Dyslipidemias -- drug therapy
- Female
- Humans
- Insulin Resistance
- Male
- Middle Aged
- PPAR alpha -- agonists
- PPAR gamma -- agonists
- Phenylpropionates -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.